9, a gain of 5. 335. They are not that cheap. PNV going from strength to strength. , page-282. Created with Sketch. Shares in Polynovo are soaring this afternoon, after the medical device developer reported an unexpected jump in revenue in August. PNV going from strength to strength. PNV going from strength to strength. , page-291. 86m to grow maiden resourceBut the ASX 200 index was at 6451. It will be difficult but if it succeeds it will showcase the advatntages of BTM. I guess daily volumes of shorts don't matter too much here on PNV It's the compounded effect IMO as can be seen below the Overall Short position is increasing Hasn't usually had a 3 day run but now that it's done a counter trend bounce straight into downtrend resistance line, we may see this turning red tomorrowI didn't think ASX allowed these promotional tactics anymore!! The Chairman is just using it as a tactic to generate market attention and put pressure on shorters. , page-291. ASX - Day TradingSo AVH, loss of 15m last half year. I didn't think ASX allowed these promotional tactics anymore!! The Chairman is just using it as a tactic to generate market attention and put pressure on shorters. Latest Posts. Why wait for $1. I didn't think ASX allowed these promotional tactics anymore!! The Chairman is just using it as a tactic to generate market attention and put pressure on shorters. It also suggests the CEO is quite weak in preventing these shenanigans, which is a major concern. 14 Sentiment: Buy Disclosure: HeldI didn't think ASX allowed these promotional tactics anymore!! The Chairman is just using it as a tactic to generate market attention and put pressure on shorters. The recent lows have been a massive opportunity for people with a longer term view to get set. The big one for me from a sales execution point of view if ARX have 33 field sales reps and 7 inside sales- they are getting a lot of coverage of their products, leveraging the recent GPO signing with Premier- employees of PNV have stated previously the top 5 GPOS in the US represent 90% of hospital coverage- no one company has signed all 5. 3M ! Add to my watchlist Healthcare, Medical Instruments & Supplies PolyNovo Limited is an. As you say the others offer little other than generalised opinions and have little understanding of the products, the company and it's actual competitors. PNV going from strength to strength. PNV going from strength to strength. Good set-up for a break-out above 0. 0¢. 45. 45 is a 1b market cap. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you. Management would acknowledge that new starts and training impacts their sales force's efficiency as there is none else to do it. $1. Good set-up for a break-out above 0. PNV Price at posting: $1. PNV going from strength to strength. , page-291. Thought it might be worth starting a thread specifically on short activity. Good set-up for a break-out above 0. Yes, he has been brilliant. (please be aware the top 200 ASX companies are not simply the ASX200, there are lots of exclusions on liquidity, public float, etc) There has been a lot of conjecture on whether PNV was leaving the ASX200 mid-June. That is one reason IMO the BOD is pouring every spare dollar earned into expanding the customer base and uses for the product. 40 resistance. , page-291. Good set-up for a break-out above 0. 9, a gain of 5. 38- 0. Last updated 13. 45 is a 1b market cap. 40 resistance. Of course $1. 38- 0. PolyNovo Limited (PNV. Latest Posts. 40 resistance. 2 million views HotCopper has news, discussion, prices and market data on POLYNOVO LIMITED. 13. PNV going from strength to strength. PNV going from strength to strength. Click for more information. And it will be interesting to see how well ARX and PNV compete in the foot ulcer areas with a different focus. 35. 40 resistance. Created with Sketch. Created with Sketch. PNV therefore is a great way of determining just how high the price of EYE could run if we can get the predicted sales growth. 38%. 39 polynovo limited. 38- 0. , page-277. 38- 0. PNV going from strength to strength. 40 resistance. 9 on that day and is now at 6826. • Unless otherwise requested by the Company, PNV requests the trading halt to remain in place until the release of an announcement on the above or until Wednesday 3 May 2023; and • The Company is not aware of any reason why the trading halt should not be granted or of any other information necessary to inform the market about the trading halt. Volume. 935 - ADX>25 - Daily RS +ve - Daily FFI +ve - Weekly RS -ve - Weekly FFI +ve - Moving. Good set-up for a break-out above 0. PNV is early stage growth with the possibility of becoming global standard of care across a few indications if market share growth continues. The biggest factor here is time and the faster PNV establishes the product as std of care in as many verticals as possible, the less attractive it will be for a competitor. 40 resistance. 9 on that day and is now at 6826. Management would acknowledge that new starts and training impacts their sales force's efficiency as there is none else to do it. PNV has secured ~ $800,000 sales in a $800,000,000 market - is that only 0. 45 is a 1b market cap. PNV Price at posting: $1. Even without going into the specifics of the product and the industry, the nuances of which you don't seem to understand despite claiming to be a doctor, just those simple numbers tell a much different story than the. PNV going from strength to strength. , page-291. Add PNV (ASX) to my watchlist. 40 resistance. 8% so its not like its very different to the whole index. It also suggests the CEO is quite weak in preventing these shenanigans, which is a major concern. 41. 40 resistance. Created with Sketch. Last updated 15. , page-291. 40 resistance. Forums. 40 resistance. Achieve FY24 profit & PNV demonstrates (again) the growth trajectory and bottom line mgt, as per comments by TheAnalyst007. , page-291. $1. They are not that cheap. , page-291. I think long term use of BTM in India will accentuate and highlight the many benefits of BTM compared to the biologics that can't compete due to direct cost, refrigeration, indirect costs including inpatient. Latest Posts. gmutton: "Macquarie has increased price target to $ 2. Price Movement (20 mins delayed) 52 Week Range - 1 Year Return Polynovo Ltd Chart and Price Data Fundamentals Data provided by Morningstar. It also suggests the CEO is quite weak in preventing these shenanigans, which is a major concern. 38- 0. ASX - By Stock: PNV: Re: PNV - Banter and General Comments : Thread: Lectroid. 38- 0. 0¢. , page-291. 56 Sentiment: Buy Disclosure: Held. PNV going from strength to strength. I'm not watching PNV market depth at the moment but for two weeks in June i watched it for the whole session each day. Lack of liquidity plays into their hands so they can control the price easily. 38- 0. REGULATION. @ThereAbouts you should repost that every times he posts . Join the HotCopper ASX share market forum today for free. A big thank you to 'acouch' for the regular PNV Chart information postings, ( and very sad to hear about the beautiful canine). PNV is on the list of companies 'investors' can short through them. Bell Direct market analyst, Grady Wulff, discusses 5 ASX healthcare stocks, one of which is PNV. I didn't think ASX allowed these promotional tactics anymore!! The Chairman is just using it as a tactic to generate market attention and put pressure on shorters. 40 resistance. , page-290. 25. Expand Honest question, did DW really say 50% to 100% growth yoy for 5-8 years? Manage Cookie Settings. PNV/Management aren’t switching from growth stock in 2021 to value stock in 2023 just because market wants them to be profitable. 41%) Polynovo Limited (PNV), an ASX-listed company, is involved in the development of f innovative medical devices for a number of. , page-291. Good set-up for a break-out above 0. Melbourne wound healing technology manufacturer PolyNovo (ASX: PNV) has capped off a string of recent successes with a deal that will see it enter the defence market in the United States. , page-291. $1. 40 resistance. 45 is a 1b market cap. Latest Posts. 210929. , page-290. PNV going from strength to strength. 40 resistance. , page-291. 40 resistance. 90 less than 12 months ago, with a share price now around $1. PNV going from strength to strength. , page-291. HotCopper stats: 15000 comments, 7. It confused me and I am not surprised it confused holders and the rest of the market. , page-291. 38- 0. They are not that cheap. $1. 8% so its not like its very different to the whole index. let's say they earn $100m revenue and let's say $10m bottom line Npat FY24 as an example, that's a PE of 100 in an environment we're cash, offset accounts are at 6%+ risk free. Created with Sketch. *Close price adjusted for splits. Good set-up for a break-out above 0. 21 Sentiment: Hold Disclosure. Good set-up for a break-out above 0. 40 resistance. 38- 0. AX) stock quote,. That is one reason IMO the BOD is pouring every spare dollar earned into expanding the customer base and uses for the product. $1. Management would acknowledge that new starts and training impacts their sales force's efficiency as there is none else to do it. 42%. 38- 0. Good set-up for a break-out above 0. 11:45:20 AM 1. 210929. Longer term readers and posters will be aware I've been recording monthly BTM sales revenue since the start of PNV and have shown those modelled results. 41%) Polynovo Limited (PNV), an ASX-listed company, is involved in the development of f innovative medical devices for a number of medical applications, utilising the patented bioabsorbable polymer technology NovoSorb. 38- 0. not just recommending moving out of a position - but to others who don't even have a position, but want to bet on a fall ). The BTM device, as you know it, largely resulted from work performed in 2009-2010 (see below) under Calzada. ASX - Day Trading. 70 has already $70mil of annual revenue and break even counted in for 2023FY. Even more, it is important to note that with revenue of $3m (significantly below that of EYE's current revenue of $17M), it started with a market cap of $150m (compared to EYE's current market cap of $38m). 38- 0. , page-290. Asx 200 was up 115 points. , page-181. PNV going from strength to strength. 38- 0. It also suggests the CEO is quite weak in preventing these shenanigans, which is a major concern. 40 resistance. PNV going from strength to strength. PNV going from strength to strength. 40 resistance. Created with Sketch. 018 1. $1. They are not that cheap. But the ASX 200 index was at 6451. PNV going from strength to strength. , page-285. This follows an impressive Q3 FY23 performance. Forex. 45 is a 1b market cap. , page-274. 40 resistance. let's say they earn $100m revenue and let's say $10m bottom line Npat FY24 as an example, that's a PE of 100 in an environment we're cash, offset accounts are at 6%+ risk free. rights. Good set-up for a break-out above 0. Stable but sitting at a relatively high level . 00 Fy23 revenue guide Us$51m-53m, Mcap A$638. By now, you’ve heard about lithium batteries for EVs. If you could offer calculations, considered criticism or industry/market intelligence to bag PNV with; then fair enough. 005 0. let's say they earn $100m revenue and let's say $10m bottom line Npat FY24 as an example, that's a PE of 100 in an environment we're cash, offset accounts are at 6%+ risk free. August revenue totalled $7. $1. Created with Sketch. 470 TP1: 1. Latest Posts. Good set-up for a break-out above 0. Users also quote an 'Australian discount' on domestic biotechnology companies. They are not that cheap. Healthcare, Medical. 1M: Open: High: Low: Value: Volume: $1. Created with Sketch. 38- 0. Looking forward to many more Indian surgeons converting to the use of BTM and joining "The Swami Army", as they appreciate the benefits. 0¢. Looking forward to seeing the role played by Polynovo and Novosorb BTM in the stories of each of the participants in this expedition. I didn't think ASX allowed these promotional tactics anymore!! The Chairman is just using it as a tactic to generate market attention and put pressure on shorters. PNV going from strength to strength. PNV going from strength to strength. Lack of liquidity plays into their hands so they can control the price easily. 40 resistance. 38- 0. They don’t need to flip the switch to profitability today because they know if they keep delivering growth, when they want to be profitable they can flip the switch. Stabilising at just over 4% - #49 on the Top 100 shorted ASX shares. , page-290. 40 resistance. , page-291. Good set-up for a break-out above 0. Latest Posts. PNV going from strength to strength. PNV/Management aren’t switching from growth stock in 2021 to value stock in 2023 just because market wants them to be profitable. 26. 0 Great analysis. 38- 0. 0¢. 38- 0. 0. , page-290. 32. Become a member of Australia's largest investment discussion forum. , page-291. 38- 0. The recent pump got me interested in PNV as it caught my intention. 40 resistance. 38- 0. , page-291. 00%. The SP of $2. PNV going from strength to strength. View the detailed maiden research report produced by Arrowhead, providing an in-depth summary of the emerging green steel leader, Magnum Mining and Exploration, as they announce a promising partnership with the Saudi based Midmetals. ASX - By Stock; PNV; Goodbye HotCopper; PNV. Market . 38- 0. I dont think the shorts are overconcerned. Created with Sketch. 38- 0. 9, a gain of 5. 205 0. Created with Sketch. 008 ( 0. Shorting PNV are not a good long term bet, even if selling short might offer a limited term opportunistic opportunity if the share price gets out over its skis just a bit on the way up. 7 million, more than double its year-earlier revenue of $3. 45 polynovo limited. , page-291. PNV going from strength to strength. They are not that cheap. 27. , page-291. 31: $1. They are not that cheap. 7 million, more than double its year-earlier revenue of $3. PNV going from strength to strength. New ASX code MKT launches today. 40 resistance. 045(3. Market Average Movement. Development of innovative medical devices for a number of medical applications, utilising the patented bioabsorbable polymer technology NovoSorb. It also suggests the CEO is quite weak in preventing these shenanigans, which is a major concern. , page-84. Good set-up for a break-out above 0. It also suggests the CEO is quite weak in preventing these shenanigans, which is a major concern. , page-10349. 40 resistance. PNV/Management aren’t switching from growth stock in 2021 to value stock in 2023 just because market wants them to be profitable. PNV going from strength to strength. They are not that cheap. 45 is a 1b market cap. 2,870,271. 40 resistance. PNV going from strength to strength. ASX POLYNOVO LIMITED PNV POLYNOVO LIMITED - Discussion Market Cap $966. 1. I didn't think ASX allowed these promotional tactics anymore!! The Chairman is just using it as a tactic to generate market attention and put pressure on shorters. HotCopper has news, discussion, prices and market data on POLYNOVO LIMITED. They will have made a lot of profit on PNV over the last few years. Good set-up for a break-out above 0. Good set-up for a break-out above 0. let's say they earn $100m revenue and let's say $10m bottom line Npat FY24 as an example, that's a PE of 100 in an environment we're cash, offset accounts are at 6%+ risk free. 9 on that day and is now at 6826. They are not that cheap. PNV going from strength to strength. (ASX:CCO) breaks new ground in Australian retail with Kava shots to launch in Coles from January 2024 21 Nov 2023 THE CALMER CO INTERNATIONAL LIMITED This is the first ready to drink kava product to hit the Australian market and the first kava-based drink launched into the fast growing “low/no” alcohol. In fact they love the swill. 45 is a 1b market cap. They don’t need to flip the switch to profitability today because they know if they keep delivering growth, when they want to be profitable they can flip the switch. , page-290. The monthly chart has indicated a Downtrend reversal is in Play and we will start a mini bull run from February till June / July where I expect the price to cool off before the. I didn't think ASX allowed these promotional tactics anymore!! The Chairman is just using it as a tactic to generate market attention and put pressure on shorters. PNV going from strength to strength. Latest Posts. PNV going from strength to strength. PNV Board keeping the faith with shareholders. 45 is a 1b market cap. I didn't think ASX allowed these promotional tactics anymore!! The Chairman is just using it as a tactic to generate market attention and put pressure on shorters. I didn't think ASX allowed these promotional tactics anymore!! The Chairman is just using it as a tactic to generate market attention and put pressure on shorters. 9 on that day and is now at 6826. 500287. The Clinicians Speak, page-10. 9, a gain of 5. You can make your own assessment of PNV based on FA vs the current SP, and determine whether it's good value atm or not. 0. To make money (inc to cover costs) they simply need to do what we do, except in reverse. PolyNovo Limited is an Australia-based medical devices company focused on the development. The biggest factor here is time and the faster PNV establishes the product as std of care in as many verticals as possible, the less attractive it will be for a competitor. $1. HotCopper has news, discussion, prices and market data on ADVANCE METALS LIMITED. 9 on that day and is now at 6826. 13. That is one reason IMO the BOD is pouring every spare dollar earned into expanding the customer base and uses for the product. PNV going from strength to strength. It also suggests the CEO is quite weak in preventing these shenanigans, which is a major concern. It also suggests the CEO is quite weak in preventing these shenanigans, which is a major concern. 38- 0. 40 resistance. Commodities. $1. PNV going from strength to strength. 14 Sentiment: Buy Disclosure: HeldDon't miss out on insights from industry leaders and ASX-listed giants like Vulcan Energy Resources, Infinity Lithium, Power Minerals, and Forrestania. 38- 0. Good set-up for a break-out above 0. They expect sales for sure.